NIH Grants for Diabetes Research Tech

Posted: August 27, 2014

This grant closed on Mar 03, 2015. We have found similar active grants for you below.

Summary

This NIH grant supports the development of advanced technologies to study human pancreatic tissues at a single-cell level. Funds are available for innovators aiming to understand and prevent Type 1 Diabetes progression by protecting vital beta cells.

Eligibility

Biotech Medical Research Diabetes NIH Technology Development

Full Description

This Funding Opportunity Announcement (FOA) requests applications for the development of medium- to high-throughput "omics" technologies that can be used to explore human pancreatic tissues with single cell- or near single cell- resolution. Successful applicants will join the Consortium on Beta cell Death and Survival (CBDS), whose mission is to identify the mechanisms of beta cell stress and destruction central to the development of Type 1 Diabetes (T1D) in humans, with the long-term goal of protecting the residual beta cell mass in T1D patients as early as possible in the disease process, and preventing the progression towards autoimmunity. CBDS is part of the Human Islet Research Network (HIRN).